- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06278415
Physiologically Based Cord Clamping To Improve Neonatal Outcomes After Elective Cesarean Delivery (PhyCord1)
Pilot Prospective Unblinded Randomized Controlled Study Assessing the Efficacy and Safety of Physiologically Based Cord Clamping Versus Standard Delayed Cord Clamping After Elective Scheduled Cesarean Delivery of Full-term Newborn
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The successful transition from fetal to neonatal life is a major physiological challenge that requires the coordination of lung developmental processes, which culminate with the formation of a diffusible alveolar-capillary barrier, adequate pulmonary vasoreactivity, mature surfactant system, and clearance of lung fluid. During fetal life, gas exchange does not take place in fetal lungs but in the placenta. High pulmonary vascular resistance diverts blood flow to the left atrium through the foramen ovale and to the aorta via the ductus arteriosus. The placental circulation receives 30-50 % of the fetal cardiac output and is the major source of venous return to the fetal heart. Therefore, the umbilical venous return determines the preload for the left ventricle. Shortly before birth and during labor, the lungs undergo important transitional changes. The reabsorption of lung fluid within the airways is initiated during labor by adrenaline-induced activation of sodium channels. Uterine contractions during labor and the onset of inspiration after umbilical cord clamping generate a high transpulmonary pressure gradient leading to additional clearance of fluid from the airways into the surrounding tissue . Following the first breath and lung aeration, oxygen-induced vasodilation leads to a sudden rise in pulmonary blood flow and left atrial pressures, which closes the foramen ovale. Meanwhile, systemic vascular resistance increases above the level of pulmonary vascular resistance after placental removal, which reverses blood flow across the ductus arteriosus and induces ductal closure in response to high oxygen tension.
The route of delivery can impact the success of adaptation to extrauterine life. Over the past 30 years, the rate of cesarean deliveries has increased worldwide. In Belgium, this can be as high as 20% of all deliveries. A subset of cesarean deliveries is scheduled in term infants in the absence of spontaneous labor when vaginal delivery is considered as too risky for maternal and/or child health. The so-called iterative cesarean delivery, which is usually considered as a routine and harmless option, can however alter neonatal health. By contrast with vaginal delivery, infants born at term by iterative cesarean delivery have to adapt despite larger volumes of fluid within airways and interstitial tissue resulting from a limited rise in transpulmonary pressure and adrenaline-induced fluid reabsorption. Subsequently, the retention of lung fluid is responsible for transient tachypnea of the newborn, a respiratory distress that is usually considered as mild, transient, and without sequelae. Moreover, infants born by elective cesarean delivery exhibit a higher risk of positive pressure ventilation resuscitation at birth, admission to the neonatal intensive care unit (NICU), and severe hypoxic respiratory failure requiring mechanical ventilation in the most severe cases. In addition to increased neonatal morbidity, iterative cesarean section can impact mother-infant relationship. After vaginal delivery, immediate skin-to-skin contact during the first minute after birth is the natural process recommended to support mother-infant bonding and promote early onset of breastfeeding. Despite efforts made to start skin-to-skin contact as early as possible after cesarean delivery, immediate contact is practically difficult to implement. In our institution, the infant is usually shortly separated from the mother after umbilical cord clamping to provide first care by a pediatrician before returning on the mother's chest or on the father's chest depending on parental wishes and maternal well-being during the operation. The separation between the mother and her newborn can be further extended in the case of NICU admission for transient tachypnea.
Beside the route of delivery, the timing of umbilical cord clamping can profoundly affect the process of neonatal cardiorespiratory transition. Immediate cord clamping reduces the venous return to the heart, which transiently decreases heartbeats, cardiac output and cerebral blood flow before respiration initiates and pulmonary blood flow increases. Delayed cord clamping for longer than 60 seconds improves the transfusion of blood from the placenta to the newborn. Moreover, it can increase neonatal hemoglobin levels, improve long-term iron stores, and improve neurodevelopmental outcomes. Nevertheless, in both clinical research setting and daily practice, delayed cord clamping lasts rarely more than one minute during cesarean section. More recently, another approach, referred to as physiologically based cord clamping (PBCC), has been proposed to delay cord clamping up to 5 minutes after the onset of ventilation. PBCC allows to start lung aeration while on placental support and, therefore, promotes hemodynamic transition by increasing pulmonary blood flow and maintaining left ventricle preload. This strategy has been demonstrated efficient in preterm lambs and is feasible in very preterm infants, via the use of a purpose-designed resuscitation table that allows delayed cord clamping, maintenance of body temperature, and concomitant respiratory support where necessary. First experience has reported good parental acceptance of the procedure. Because PBCC has not been reported in term infants at risk of respiratory distress after birth, the present project aims to assess whether PBCC in term infants born by elective cesarean section would not be inferior to standard umbilical cord clamping with regards to adaptation to extrauterine life, respiratory morbidity, quality of mother-infant bonding, and maternal safety.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna AMORUSO
- Phone Number: +3224773250
- Email: anna.amoruso@hubruxelles.be
Study Contact Backup
- Name: Andrew CARLIN
- Phone Number: +3224773295
- Email: andrew.carlin@chu-brugmann.be
Study Locations
-
-
-
Brussels, Belgium, 1020
- Recruiting
- CHU Brugmann
-
Contact:
- Andrew CARLIN
- Phone Number: +3224773295
- Email: andrew.carlin@chu-brugmann.be
-
Principal Investigator:
- Andrew CARLIN, MD
-
Brussels, Belgium, 1020
- Recruiting
- Hôpital Universitair Des Enfants Reine Fabiola
-
Contact:
- Anna AMORUSO
- Phone Number: +3224773250
- Email: anna.amoruso@hubruxelles.be
-
Principal Investigator:
- Anna AMORUSO, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if:
- Scheduled for cesarean delivery (business days and daily working hours)
- Singleton pregnancy
- Cesarean section scheduled at or after 37 weeks gestational age
Exclusion Criteria:
- Fetal anomalies (congenital malformations, anemia, growth restriction with abnormal Dopplers)
- Abnormal placentation (placenta previa)
- Signs of fetal distress necessitating an emergency cesarean section
- Spontaneous labor before cesarean section
- Maternal health issue including severe anemia (defined as hemoglobin level < 7 g/dL), preeclampsia, and bleeding disorders
- Maternal refusal of the use of blood products.
- General anesthesia for cesarian section
- Planned cord blood banking
- Total language barrier without possibility of translation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Physiological based cord clamping (PBCC)
In the intervention group, newborns will receive PBCC.
The resuscitation table will place in the operating room as close as possible to the mother's pelvis.
After the infant is born, the obstetrician holds the infant.
Stabilization will start as soon as the infant is placed on the platform.
The nurse places the oximeter sensor on the right wrist and ECG electrodes on the chest of the newborn.
Local resuscitation guidelines will be in respect of the NLS-ERC 2021 guidelines.
Stabilization of the newborn will be performed while the cord is intact and the cord will be clamped after respiratory stabilization will be achieved, defined as the establishment of regular spontaneous breathing, a HR above 100 bpm SpO 2 above 85% while using supplemental oxygen less than 0,3.
|
see Arm Description
|
|
Active Comparator: Differed cord clamping (DCC)
In the control group, newborns will receive standard DCC defined as time based and performed at 60 seconds after birth.
Then infants will be transferred to a standard resuscitation table located in a stabilization room next to the operating room.
Further treatment and intervention required for cardiopulmonary stabilization will be provided on the standard resuscitation table.
Stabilization will start as soon as the infant is placed on the resuscitation table.
The nurse will place the oximeter sensor on the right wrist and ECG electrodes on the chest of the newborn.
Local resuscitation guidelines will be in respect of the NLS-ERC 2021 guidelines.
The time to reach the stabilisation described above (a HR above 100 bpm and SpO 2 above 85% while using supplemental oxygen less than 0,3) is recorded.
Then, the infant will be placed on the mother's chest or partner's chest, or alternatively, be prepared and transferred to the transport incubator if further neonatal care is needed.
|
see Arm Description
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of neonatal mortality
Time Frame: within 28 days of delivery
|
within 28 days of delivery
|
|
|
Rate of neonatal resuscitation
Time Frame: within first 10 minutes of life
|
Neonatal resuscitation is defined as the use of a T-piece resuscitator for continuous airway positive pressure or intermittent positive pressure (with or without oxygen supplementation).
|
within first 10 minutes of life
|
|
Rate of neonatal respiratory morbidity
Time Frame: within first 24 hours of life
|
Neonatal respiratory morbidity includes transient tachypnea of the newborn, air leak syndrome and respiratory distress syndrome.
|
within first 24 hours of life
|
|
Number of admission to the NICU or special care baby unit
Time Frame: within first 72 hours of life
|
within first 72 hours of life
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success of PBCC
Time Frame: within first 10 minutes of life
|
Measured by the percentage of neonates in whom the procedure will be achieved without issue, identification of failed PBCC, and duration of stabilization with PBCC (defined as spontaneous breathing heart rate >100 bpm, oxygen saturation by pulse oximetry ≥ 85% with inspired oxygen fraction < 0.3).
|
within first 10 minutes of life
|
|
Time to first breath/cry
Time Frame: post delivery
|
Time in seconds
|
post delivery
|
|
Changes in physiological variables during neonatal transition
Time Frame: within first 10 minutes of life
|
Physiological variables include measurements of preductal oxygen saturation by pulse oximetry (in %) and gases, as well as Apgar scores at 1, 5, and 10 minutes.
|
within first 10 minutes of life
|
|
Changes in physiological variables during neonatal transition
Time Frame: within first 10 minutes of life
|
Physiological variables include measurements of respiratory rate and heart rate (in number per minute)
|
within first 10 minutes of life
|
|
Changes in physiological variables during neonatal transition
Time Frame: within first 10 minutes of life
|
Physiological variables include measurements of body temperature (in degrees Celcius)
|
within first 10 minutes of life
|
|
Changes in physiological variables during neonatal transition
Time Frame: within first 10 minutes of life
|
Physiological variables include measurements of umbilical cord venous hemoglobin (in gr/dl)
|
within first 10 minutes of life
|
|
Changes in physiological variables during neonatal transition
Time Frame: within first 10 minutes of life
|
Physiological variables include measurements of umbilical cord pH
|
within first 10 minutes of life
|
|
Changes in physiological variables during neonatal transition
Time Frame: within first 10 minutes of life
|
Physiological variables include measurements of Apgar scores (from 1 to 10 units on the scale, the highest scores meaning better outcome) at 1, 5 and 10 minutes
|
within first 10 minutes of life
|
|
Early neonatal parameters
Time Frame: within the first 3 hours of life
|
Early neonatal parameters include body temperature (in degrees Celcius) at 1, 2 and 3 hours of life.
|
within the first 3 hours of life
|
|
Early neonatal parameters
Time Frame: within first 24 hours of life
|
Early neonatal parameters include body weight (in gramme).
|
within first 24 hours of life
|
|
Hemoglobin level
Time Frame: at 48 hours of life
|
in g/dl
|
at 48 hours of life
|
|
Bilirubin level
Time Frame: at 48 hours of life
|
in mg/dl
|
at 48 hours of life
|
|
Number of neonatal adverse events
Time Frame: within first 72 hours of live
|
including hypoglycemia, sepsis, and the need for phototherapy.
|
within first 72 hours of live
|
|
Maternal perioperative parameters
Time Frame: at Day 1 post delivery
|
Maternal perioperative parameters include total surgical time (in minutes), intraoperative intravenous fluid volume, intraoperative blood loss, uterotonic administration, and postoperative hemoglobin level at day 1.
|
at Day 1 post delivery
|
|
Maternal perioperative parameters
Time Frame: at Day 1 post delivery
|
Maternal perioperative parameters include intraoperative intravenous fluid volume and intraoperative blood loss (in ml), uterotonic administration, and postoperative hemoglobin level at day 1.
|
at Day 1 post delivery
|
|
Maternal perioperative parameters
Time Frame: at Day 1 post delivery
|
Maternal perioperative parameters include uterotonic administration (Yes/No), and postoperative hemoglobin level at day 1.
|
at Day 1 post delivery
|
|
Maternal perioperative parameters
Time Frame: at Day 1 post delivery
|
Maternal perioperative parameters include postoperative hemoglobin level (in gr/dl).
|
at Day 1 post delivery
|
|
Number of maternal adverse events
Time Frame: within first 2 weeks post delivery
|
Maternal adverse events include death, blood transfusion, postpartum hemorrhage, hysterectomy, admission in the Intensive Care Unit, wound seroma, and wound cellulitis.
|
within first 2 weeks post delivery
|
|
Rate of maternal-infant bonding
Time Frame: up to 2 weeks post delivery
|
breastfeeding (yes/no)
|
up to 2 weeks post delivery
|
|
Rate of maternal-infant bonding
Time Frame: at 2 weeks post delivery
|
maternal depression (measured by the Edinburgh Postnatal Depression Scale (EPDS) - score min = 0, score max = 30, higher score = worse outcome)
|
at 2 weeks post delivery
|
|
Rate of maternal-infant bonding
Time Frame: at 2 weeks post delivery
|
maternal depression (measured by the Maternal Infant Bonding Scale (MIBS) - score min = 0, score max = 24, higher score = worse outcome)
|
at 2 weeks post delivery
|
|
Parental satisfaction survey
Time Frame: at 2 weeks post delivery
|
at 2 weeks post delivery
|
|
|
Child developmental assessment
Time Frame: at 2 weeks postnatally
|
The child developmental assessment is done using the Brazelton Neonatal Behavioral Assessment Scale (NBAS) - score min = 1, score max = 6, higher score = better outcome
|
at 2 weeks postnatally
|
Collaborators and Investigators
Investigators
- Principal Investigator: Anna AMORUSO, Huderf
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P2021/Neonat/PhyCord 1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transient Tachypnea of the Newborn
-
New York Hospital QueensCompleted
-
Zekai Tahir Burak Women's Health Research and Education...UnknownTransient Tachypnea of NewbornTurkey
-
Khyber Teaching HospitalCompleted
-
University of CologneCompletedTransient Tachypnoea of the NewbornGermany
-
Benha UniversityCompletedTransient Tachypnea of Newborn and Fetal AcidosisEgypt
-
Makassed General HospitalCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedRespiratory Distress Syndrome | Transient Tachypnea of Newborn
-
University Hospital, Strasbourg, FranceUnknownTransient Tachypnoea of the NewbornFrance
-
Ain Shams UniversityUnknownCesarean Delivery Affecting Fetus | Transient Tachypnea NewbornEgypt
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedRespiratory Distress Syndrome | Intrauterine Growth Retardation | Transient Tachypnea of NewbornTurkey
Clinical Trials on Physiological based cord clamping
-
Leiden University Medical CenterErasmus Medical Center; Academisch Medisch Centrum - Universiteit van Amsterdam... and other collaboratorsCompleted
-
Queen Fabiola Children's University HospitalThe Belgian Kids Fund; Fonds IRIS-Recherche; Ars StatisticaRecruitingSepsis | Premature Birth | Jaundice | Respiratory Distress Syndrome in Premature Infant | Intraventricular Hemorrhage of Prematurity | BronchodysplasiaBelgium
-
Medical University of GrazCompletedNear-Infrared Spectroscopy | Umbilical Cord IssueAustria
-
Helse Møre og Romsdal HFNorwegian University of Science and TechnologyCompletedInfant Conditions | Cesarean SectionNorway
-
Uppsala UniversityUNICEF; Ministry of Health and Population, Nepal; Swedish Society for Medical...CompletedAsphyxia Neonatorum | Neonatal DisorderNepal
-
Uppsala UniversityUNICEF; Ministry of Health and Population, Nepal; The Swedish Society of MedicineCompletedEffect of Timing of Umbilical Cord Clamping on Anaemia at 8 and 12 Months and Later NeurodevelopmentAnemia | Iron Deficiency | Neonatal JaundiceNepal
-
Benha UniversityRecruiting
-
University of Rhode IslandNational Institute of Nursing Research (NINR); Brown University; Women and Infants...CompletedSepsis | Intraventricular HemorrhageUnited States
-
Hainan Medical CollegeUnknown
-
Hospital JP GarrahanRecruitingCongenital Diaphragmatic Hernia | Umbilical Cord Clamping | Delayed Umbilical Cord SeparationArgentina